Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Stübiger N[au]:

[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis]. Kötter I et al. Z Rheumatol. (2017)

[Ocular lymphoma: diagnosis and therapy]. Stübiger N et al. Ophthalmologe. (2015)

[Intraocular inflammation in multiple sclerosis]. Stübiger N et al. Ophthalmologe. (2018)

Search results

Items: 1 to 50 of 75

1.

[Acute unilateral non-traumatic enophthalmus].

Mehlan J, Dulz S, Stübiger N, Schuettauf F.

Ophthalmologe. 2019 Jul;116(7):673-676. doi: 10.1007/s00347-018-0797-7. German. No abstract available.

PMID:
30367234
2.

[Intraocular inflammation in multiple sclerosis].

Stübiger N, Ruprecht K, Pleyer U.

Ophthalmologe. 2018 Jun;115(6):531-542. doi: 10.1007/s00347-018-0673-5. German.

PMID:
29536169
3.

Multimodal Imaging in Birdshot Retinochoroiditis.

Pohlmann D, Macedo S, Stübiger N, Pleyer U, Joussen AM, Winterhalter S.

Ocul Immunol Inflamm. 2017 Oct;25(5):621-632. doi: 10.1080/09273948.2017.1375532.

PMID:
29083980
4.

[Ocular involvement in rheumatoid arthritis, connective tissue diseases and vasculitis].

Kötter I, Stübiger N, Deuter C.

Z Rheumatol. 2017 Oct;76(8):673-681. doi: 10.1007/s00393-017-0372-7. Review. German.

PMID:
28861674
5.

Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.

Rübsam A, Thieme CE, Schlomberg J, Winterhalter S, Müller B, Joussen AM, Stübiger N.

J Ocul Pharmacol Ther. 2017 Apr;33(3):141-148. doi: 10.1089/jop.2016.0068. Epub 2017 Mar 9.

PMID:
28277988
6.

[Treatment of posterior noninfectious uveitis : Current situation and future developments].

Pleyer U, Pohlmann D, Stübiger N.

Ophthalmologe. 2016 May;113(5):380-90. doi: 10.1007/s00347-016-0267-z. Review. German.

PMID:
27165275
7.

Correction: Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography.

Ouyang Y, Li F, Shao Q, Heussen FM, Keane PA, Stübiger N, Sadda SR, Pleyer U.

PLoS One. 2015 Jul 21;10(7):e0134074. doi: 10.1371/journal.pone.0134074. eCollection 2015. No abstract available.

8.

Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomography.

Ouyang Y, Li F, Shao Q, Heussen FM, Keane PA, Stübiger N, Sadda SR, Pleyer U.

PLoS One. 2015 May 26;10(5):e0127683. doi: 10.1371/journal.pone.0127683. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134074.

9.

[Diagnostics and treatment of primary vitreoretinal lymphoma].

Stübiger N, Kakkassery V, Gundlach E, Winterhalter S, Pleyer U.

Ophthalmologe. 2015 Mar;112(3):223-30. doi: 10.1007/s00347-014-3204-z. German.

PMID:
25698590
10.

[Lymphoma of the ocular adnexa].

Kakkassery V, Stübiger N, Adamietz IA, Tischoff I, Baraniskin A, Wunderlich IM.

Ophthalmologe. 2015 Mar;112(3):210-6. doi: 10.1007/s00347-014-3205-y. Review. German.

PMID:
25693875
11.

[Ocular lymphoma: diagnosis and therapy].

Stübiger N.

Ophthalmologe. 2015 Mar;112(3):208-9. doi: 10.1007/s00347-014-3173-2. German. No abstract available.

PMID:
25693874
12.

New pharmacotherapy options for noninfectious posterior uveitis.

Pleyer U, Stübiger N.

Expert Opin Biol Ther. 2014 Dec;14(12):1783-99. doi: 10.1517/14712598.2014.956074. Epub 2014 Sep 22. Review.

PMID:
25243865
13.

[Posterior uveitis. Part 1: diagnostics and basic concepts of therapy].

Heiligenhaus A, Breitbach M, Spital G, Stübiger N, Winterhalter S, Deuter C, Becker M, Mackensen F.

Klin Monbl Augenheilkd. 2014 Apr;231(4):457-69; quiz 470-1. doi: 10.1055/s-0033-1357916. Epub 2014 Apr 25. German. No abstract available.

PMID:
24771192
14.

[Posterior uveitis. Part 2: specific disorders].

Heiligenhaus A, Breitbach M, Spital G, Stübiger N, Winterhalter S, Deuter C, Becker M, Mackensen F.

Klin Monbl Augenheilkd. 2014 May;231(5):555-79. doi: 10.1055/s-0033-1357918. Epub 2014 Apr 24. German. No abstract available.

PMID:
24764170
15.

Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomography.

Ouyang Y, Pleyer U, Shao Q, Keane PA, Stübiger N, Joussen AM, Sadda SR, Heussen FM.

PLoS One. 2014 Feb 5;9(2):e86626. doi: 10.1371/journal.pone.0086626. eCollection 2014.

16.

[Red eye--differential diagnosis and therapy].

Stübiger N.

MMW Fortschr Med. 2013 Apr 4;155(6):50-2. Review. German. No abstract available.

PMID:
23700698
17.

[Behcet's disease--ophthalmological and general aspects: Part 2: Therapy].

Pleyer U, Hazirolan D, Winterhalter S, Stübiger N.

Ophthalmologe. 2013 Mar;110(3):273-84. doi: 10.1007/s00347-012-2780-z. German.

PMID:
23504099
18.

[Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].

Pleyer U, Hazirolan D, Winterhalter S, Stübiger N.

Ophthalmologe. 2012 Nov;109(11):1129-41; quiz 1142-3. doi: 10.1007/s00347-012-2698-5. Review. German.

PMID:
23179819
19.

[Inflammatory choroidal neovascularisations].

Winterhalter S, Joussen AM, Pleyer U, Stübiger N.

Klin Monbl Augenheilkd. 2012 Sep;229(9):897-904. doi: 10.1055/s-0032-1315249. Epub 2012 Sep 12. Review. German.

PMID:
22972355
20.

[Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?].

Pleyer U, Hazirolan D, Stübiger N.

Ophthalmologe. 2012 Jun;109(6):563-7. doi: 10.1007/s00347-012-2586-z. German.

PMID:
22699947
21.

[Typical and atypical ocular manifestations of Behçet's disease].

Stübiger N, Pleyer U.

Ophthalmologe. 2012 Jun;109(6):558-62. doi: 10.1007/s00347-012-2587-y. German.

PMID:
22699946
22.

[Behçet's disease. Epidemiology, clinical manifestations, immunology and therapy].

Stübiger N.

Ophthalmologe. 2012 Jun;109(6):529-30. doi: 10.1007/s00347-011-2505-8. German. No abstract available.

PMID:
22699942
23.

Light on the horizont: biologicals in Behçet uveitis.

Hazirolan D, Stübiger N, Pleyer U.

Acta Ophthalmol. 2013 Jun;91(4):297-306. doi: 10.1111/j.1755-3768.2011.02348.x. Epub 2012 Apr 20. Review.

24.

Interferon-α therapy in noninfectious uveitis.

Deuter C, Stübiger N, Zierhut M.

Dev Ophthalmol. 2012;51:90-7. doi: 10.1159/000336324. Epub 2012 Apr 17. Review.

PMID:
22517207
25.

Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases.

Deuter CM, Gelisken F, Stübiger N, Zierhut M, Doycheva D.

Ocul Immunol Inflamm. 2011 Jun;19(3):216-8. doi: 10.3109/09273948.2011.562341.

PMID:
21595541
26.

[Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology].

Stübiger N, Winterhalter S, Pleyer U, Doycheva D, Zierhut M, Deuter C.

Ophthalmologe. 2011 Mar;108(3):204-12. doi: 10.1007/s00347-010-2261-1. Review. German.

PMID:
21350868
27.

[Anti-TNF-α treatment for uveitis. Analysis of the current situation].

Pleyer U, Mackensen F, Winterhalter S, Stübiger N.

Ophthalmologe. 2011 Jan;108(1):13-20. doi: 10.1007/s00347-010-2256-y. Review. German.

PMID:
21181169
28.

[Arthrogryposis multiplex congenita and retinitis pigmentosa].

Stübiger N, Biester S, Deuter C, Zrenner E, Besch D.

Ophthalmologe. 2009 Dec;106(12):1121-5. doi: 10.1007/s00347-009-1972-7. German.

PMID:
19499227
29.

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis.

Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M.

Br J Ophthalmol. 2009 Jul;93(7):906-13. doi: 10.1136/bjo.2008.153874. Epub 2009 Mar 24.

PMID:
19321469
30.

Therapy of uveitis in children.

Zierhut M, Doycheva D, Biester S, Stübiger N, Kümmerle-Deschner J, Deuter C.

Int Ophthalmol Clin. 2008 Summer;48(3):131-52. doi: 10.1097/IIO.0b013e31817d7107. Review. No abstract available.

PMID:
18645406
31.

Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H.

Ann Rheum Dis. 2009 Oct;68(10):1528-34. doi: 10.1136/ard.2008.087957. Epub 2008 Apr 17. Review.

PMID:
18420940
32.

EULAR recommendations for the management of Behçet disease.

Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H; EULAR Expert Committee.

Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31.

PMID:
18245110
33.

Behçet's disease: ocular effects and treatment.

Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M.

Prog Retin Eye Res. 2008 Jan;27(1):111-36. Epub 2007 Nov 26. Review.

PMID:
18035584
34.

Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.

Kötter I, Koch S, Vonthein R, Rückwaldt U, Amberger M, Günaydin I, Zierhut M, Stübiger N.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S20-6.

PMID:
16273760
35.

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

Kötter I, Günaydin I, Batra M, Vonthein R, Stübiger N, Fierlbeck G, Melms A.

Clin Rheumatol. 2006 Jul;25(4):482-6. Epub 2005 Nov 1.

PMID:
16261281
36.

Interferon as a treatment for uveitis associated with multiple sclerosis.

Becker MD, Heiligenhaus A, Hudde T, Storch-Hagenlocher B, Wildemann B, Barisani-Asenbauer T, Thimm C, Stübiger N, Trieschmann M, Fiehn C.

Br J Ophthalmol. 2005 Oct;89(10):1254-7.

37.

Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.

Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.

Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):788-94. Epub 2005 Sep 15.

PMID:
16163494
38.

Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.

Kotter I, Deuter C, Stubiger N, Zierhut M.

J Rheumatol. 2005 Aug;32(8):1633; author reply 1634. No abstract available.

PMID:
16078350
39.

MMF and eye disease.

Zierhut M, Stübiger N, Siepmann K, Deuter CM.

Lupus. 2005;14 Suppl 1:s50-4. Review.

PMID:
15803933
40.

Uveitis in children.

Zierhut M, Michels H, Stübiger N, Besch D, Deuter C, Heiligenhaus A.

Int Ophthalmol Clin. 2005 Spring;45(2):135-56. Review. No abstract available.

PMID:
15791163
41.

Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.

Treusch M, Vonthein R, Baur M, Günaydin I, Koch S, Stübiger N, Eckstein AK, Peter HH, Ness T, Zierhut M, Kötter I.

Rheumatology (Oxford). 2004 Oct;43(10):1275-82. Epub 2004 Jul 13.

PMID:
15252211
42.

The use of interferon alpha in Behçet disease: review of the literature.

Kötter I, Günaydin I, Zierhut M, Stübiger N.

Semin Arthritis Rheum. 2004 Apr;33(5):320-35. Review.

PMID:
15079763
43.

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.

Kötter I, Vonthein R, Zierhut M, Eckstein AK, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Stübiger N.

Semin Arthritis Rheum. 2004 Apr;33(5):311-9.

PMID:
15079762
44.

Therapeutic implications for interferon-alpha in arthritis.

Kötter I, Stübiger N.

J Rheumatol. 2004 Mar;31(3):624-5; author reply 625. No abstract available. Erratum in: J Rheumatol. 2004 Apr;31(4):833.

PMID:
14994421
45.

[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].

Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.

Ophthalmologe. 2004 Feb;101(2):129-34. German.

PMID:
14991308
46.

Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis.

Kötter I, Vonthein R, Müller CA, Günaydin I, Zierhut M, Stübiger N.

J Rheumatol. 2004 Jan;31(1):133-9.

PMID:
14705232
47.

[Familial uveitis. Forms and incidence in patients at the University Eye Hospital Tubingen].

Deuter CM, Stübiger N, Siepmann K, Derse M, Zierhut M.

Ophthalmologe. 2003 Sep;100(9):713-9. German.

PMID:
14504896
48.

Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I.

Stübiger N, Crane IJ, Kötter I, Lamont GR, Zoeller M, Günthert U, Forrester JV, Zierhut M, Stiemer RH.

Adv Exp Med Biol. 2003;528:537-40. No abstract available.

PMID:
12918759
49.

Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease.

Treusch M, Stübiger N, Vonthein R, Baur M, Koch S, Günaydin I, Kanz L, Zierhut M, Kötter I.

Adv Exp Med Biol. 2003;528:533-5. No abstract available.

PMID:
12918758
50.

Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a.

Stübiger N, Besch D, Deuter CM, Zierhut M, Kötter I.

Adv Exp Med Biol. 2003;528:529-32. No abstract available.

PMID:
12918757

Supplemental Content

Loading ...
Support Center